BridgeMD
New treatment option for Prostate Cancer Metastatic Disease
Official title Role of Race in Nutritional Approach in Men on ADT
ClinicalTrials.gov ID: NCT06682390
What this study is testing
- What it's testing
- There is a well-documented association between androgen deprivation therapy (ADT) and cardiovascular morbidity. A majority of men on ADT gain weight contributing to an increase in cardiovascular risk factors (CVRFs) and cardiovascular morbidity.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- \>12 months on ADT
- Expected continuation of ADT for \>6 months upon initiation of study procedures
- Serum testosterone \<50 ng/dL
- BMI \>25
- Age \>18 years old
You likely can't join if
- Life expectancy \< 1 year
- Females
- Radiation or chemotherapy treatment
- History of diabetes or serious medical condition including uncontrolled hypertension, liver, kidney, and cardiovascular disease
- Any subject with a screening laboratory value outside of the laboratory normal range that is considered clinically significant for study...
- Any subject who currently uses tobacco products
See the full eligibility criteria
- \>12 months on ADT
- Expected continuation of ADT for \>6 months upon initiation of study procedures
- Serum testosterone \<50 ng/dL
- BMI \>25
- Age \>18 years old
- African American and Non-Hispanic white males
- people must read and sign the Institutional Review Board-approved written informed consent prior to the initiation of any study specific procedures or enrollment. A subject will be excluded for any condition that might...
- Life expectancy \< 1 year
- Females
- Radiation or chemotherapy treatment
- History of diabetes or serious medical condition including uncontrolled hypertension, liver, kidney, and cardiovascular disease
- Any subject with a screening laboratory value outside of the laboratory normal range that is considered clinically significant for study participation by the investigator
- Any subject who currently uses tobacco products
- Any use of \>20 g of alcohol per day
- Any subject who is unable or unwilling to comply with the study protocol
- Any subject who is unable to provide consent
The study team makes the final eligibility decision.
Where it's taking place
- Los Angeles, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Los Angeles, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.